311 related articles for article (PubMed ID: 25647182)
21. LRP1 Deficiency in Vascular SMC Leads to Pulmonary Arterial Hypertension That Is Reversed by PPARγ Activation.
Calvier L; Boucher P; Herz J; Hansmann G
Circ Res; 2019 Jun; 124(12):1778-1785. PubMed ID: 31023188
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory Antibodies against Activin A and TGF-β Reduce Self-Supported, but Not Soluble Factors-Induced Growth of Human Pulmonary Arterial Vascular Smooth Muscle Cells in Pulmonary Arterial Hypertension.
Kudryashova TV; Shen Y; Pena A; Cronin E; Okorie E; Goncharov DA; Goncharova EA
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30274147
[TBL] [Abstract][Full Text] [Related]
23. The miR-182/Myadm axis regulates hypoxia-induced pulmonary hypertension by balancing the BMP- and TGF-β-signalling pathways in an SMC/EC-crosstalk-associated manner.
Bai Y; Wang J; Chen Y; Lv T; Wang X; Liu C; Xue H; He K; Sun L
Basic Res Cardiol; 2021 Sep; 116(1):53. PubMed ID: 34546460
[TBL] [Abstract][Full Text] [Related]
24. AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension.
Brock M; Samillan VJ; Trenkmann M; Schwarzwald C; Ulrich S; Gay RE; Gassmann M; Ostergaard L; Gay S; Speich R; Huber LC
Eur Heart J; 2014 Dec; 35(45):3203-11. PubMed ID: 22450430
[TBL] [Abstract][Full Text] [Related]
25. MiR-339 inhibits proliferation of pulmonary artery smooth muscle cell by targeting FGF signaling.
Chen J; Cui X; Li L; Qu J; Raj JU; Gou D
Physiol Rep; 2017 Sep; 5(18):. PubMed ID: 28947594
[TBL] [Abstract][Full Text] [Related]
26. PAR-2 inhibition reverses experimental pulmonary hypertension.
Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension.
Pullamsetti SS; Doebele C; Fischer A; Savai R; Kojonazarov B; Dahal BK; Ghofrani HA; Weissmann N; Grimminger F; Bonauer A; Seeger W; Zeiher AM; Dimmeler S; Schermuly RT
Am J Respir Crit Care Med; 2012 Feb; 185(4):409-19. PubMed ID: 22161164
[TBL] [Abstract][Full Text] [Related]
28. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
[TBL] [Abstract][Full Text] [Related]
29. Altered MicroRNA processing in heritable pulmonary arterial hypertension: an important role for Smad-8.
Drake KM; Zygmunt D; Mavrakis L; Harbor P; Wang L; Comhair SA; Erzurum SC; Aldred MA
Am J Respir Crit Care Med; 2011 Dec; 184(12):1400-8. PubMed ID: 21920918
[TBL] [Abstract][Full Text] [Related]
30. miR-210 has an antiapoptotic effect in pulmonary artery smooth muscle cells during hypoxia.
Gou D; Ramchandran R; Peng X; Yao L; Kang K; Sarkar J; Wang Z; Zhou G; Raj JU
Am J Physiol Lung Cell Mol Physiol; 2012 Oct; 303(8):L682-91. PubMed ID: 22886504
[TBL] [Abstract][Full Text] [Related]
31. Transgelin exacerbates pulmonary artery smooth muscle cell dysfunction in shunt-related pulmonary arterial hypertension.
Zhou JJ; Yang J; Li L; Quan RL; Chen XX; Qian YL; Huang L; Wang PH; Li Y; Meng XM; Chen X; Gu Q; He JG
ESC Heart Fail; 2022 Oct; 9(5):3407-3417. PubMed ID: 35841124
[TBL] [Abstract][Full Text] [Related]
32. Mesenchyme homeobox 1 mediates transforming growth factor-β (TGF-β)-induced smooth muscle cell differentiation from mouse mesenchymal progenitors.
Dong K; Guo X; Chen W; Hsu AC; Shao Q; Chen JF; Chen SY
J Biol Chem; 2018 Jun; 293(22):8712-8719. PubMed ID: 29678882
[TBL] [Abstract][Full Text] [Related]
33. A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples.
Caruso P; Dempsie Y; Stevens HC; McDonald RA; Long L; Lu R; White K; Mair KM; McClure JD; Southwood M; Upton P; Xin M; van Rooij E; Olson EN; Morrell NW; MacLean MR; Baker AH
Circ Res; 2012 Jul; 111(3):290-300. PubMed ID: 22715469
[TBL] [Abstract][Full Text] [Related]
34. ALDH1A3 Coordinates Metabolism With Gene Regulation in Pulmonary Arterial Hypertension.
Li D; Shao NY; Moonen JR; Zhao Z; Shi M; Otsuki S; Wang L; Nguyen T; Yan E; Marciano DP; Contrepois K; Li CG; Wu JC; Snyder MP; Rabinovitch M
Circulation; 2021 May; 143(21):2074-2090. PubMed ID: 33764154
[TBL] [Abstract][Full Text] [Related]
35. Classical transient receptor potential channel 1 in hypoxia-induced pulmonary hypertension.
Malczyk M; Veith C; Fuchs B; Hofmann K; Storch U; Schermuly RT; Witzenrath M; Ahlbrecht K; Fecher-Trost C; Flockerzi V; Ghofrani HA; Grimminger F; Seeger W; Gudermann T; Dietrich A; Weissmann N
Am J Respir Crit Care Med; 2013 Dec; 188(12):1451-9. PubMed ID: 24251695
[TBL] [Abstract][Full Text] [Related]
36. Endothelial and Smooth Muscle Cell Interaction via FoxM1 Signaling Mediates Vascular Remodeling and Pulmonary Hypertension.
Dai Z; Zhu MM; Peng Y; Jin H; Machireddy N; Qian Z; Zhang X; Zhao YY
Am J Respir Crit Care Med; 2018 Sep; 198(6):788-802. PubMed ID: 29664678
[TBL] [Abstract][Full Text] [Related]
37. Peroxisome Proliferator-Activated Receptor γ and microRNA 98 in Hypoxia-Induced Endothelin-1 Signaling.
Kang BY; Park KK; Kleinhenz JM; Murphy TC; Green DE; Bijli KM; Yeligar SM; Carthan KA; Searles CD; Sutliff RL; Hart CM
Am J Respir Cell Mol Biol; 2016 Jan; 54(1):136-46. PubMed ID: 26098770
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-140-5p and SMURF1 regulate pulmonary arterial hypertension.
Rothman AM; Arnold ND; Pickworth JA; Iremonger J; Ciuclan L; Allen RM; Guth-Gundel S; Southwood M; Morrell NW; Thomas M; Francis SE; Rowlands DJ; Lawrie A
J Clin Invest; 2016 Jul; 126(7):2495-508. PubMed ID: 27214554
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-103/107 is involved in hypoxia-induced proliferation of pulmonary arterial smooth muscle cells by targeting HIF-1β.
Deng B; Du J; Hu R; Wang AP; Wu WH; Hu CP; Li YJ; Li XH
Life Sci; 2016 Feb; 147():117-24. PubMed ID: 26827991
[TBL] [Abstract][Full Text] [Related]
40. Nicotine Treatment Ameliorates Blood-Brain Barrier Damage After Acute Ischemic Stroke by Regulating Endothelial Scaffolding Protein Pdlim5.
Hu X; Dong J; Geng P; Sun Y; Du W; Zhao X; Wang Q; Liu C; Wang X; Liu Y; Liu W; Cheng H; Wang W; Jin X
Transl Stroke Res; 2024 Jun; 15(3):672-687. PubMed ID: 37233908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
